Published in J Ultrasound Med on October 01, 1992
Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect (2003) 2.98
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev (2013) 1.91
Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology (2010) 1.36
Uterine leiomyomas: individualizing the approach to a heterogeneous condition. Obstet Gynecol (2011) 1.26
Pregnancy-related fibroid reduction. Fertil Steril (2010) 1.05
Self-report versus ultrasound measurement of uterine fibroid status. J Womens Health (Larchmt) (2011) 1.02
Contemporary management of fibroids in pregnancy. Rev Obstet Gynecol (2010) 1.01
The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Mol Cell Endocrinol (2011) 0.97
A uterine fibroid presenting as an incarcerated umbilical hernia during pregnancy. Hernia (2005) 0.94
Postpartum factors and natural fibroid regression. Am J Obstet Gynecol (2011) 0.94
Leiomyomata uteri: hormonal and molecular determinants of growth. J Natl Med Assoc (2007) 0.90
Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells. J Clin Endocrinol Metab (2009) 0.89
Laparoscopic approach to fibroid torsion presenting as an acute abdomen in pregnancy. JSLS (2014) 0.81
Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management. Clinicoecon Outcomes Res (2015) 0.78
The rapid growth of fibroids during early pregnancy. PLoS One (2014) 0.77
Progesterone receptor action in leiomyoma and endometrial cancer. Prog Mol Biol Transl Sci (2009) 0.77
Placenta accreta associated with submucosal fibroid polyp. BMJ Case Rep (2011) 0.75
Caesarean Myomectomy: Feasibility and safety. Sultan Qaboos Univ Med J (2012) 0.75
Fetal arthrogryposis secondary to a giant maternal uterine leiomyoma. Case Rep Obstet Gynecol (2012) 0.75
Spontaneous expulsion of large submucosal uterine fibroid without embolisation - a case study. Australas J Ultrasound Med (2015) 0.75
Spontaneous Expulsion of Intramural Fibroid Six Weeks after Emergency Caesarean Section. Case Rep Obstet Gynecol (2015) 0.75
Pulmonary embolus arising from sloughed off myoma in late puerperium. J Turk Ger Gynecol Assoc (2010) 0.75
Human Chorionic Gonadotrophin as a Possible Mediator of Leiomyoma Growth during Pregnancy: Molecular Mechanisms. Int J Mol Sci (2017) 0.75
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int J Cancer (1995) 5.24
Effect of a nicotine-free inhalator as part of a smoking-cessation programme. Eur Respir J (2011) 3.25
Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause (2000) 2.27
Human immunodeficiency virus seroprevalence and condom use among female sex workers in Italy. Sex Transm Dis (1998) 1.87
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. Ann Oncol (2002) 1.82
In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chemother Pharmacol (2000) 1.77
Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer (2007) 1.72
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer (1996) 1.66
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol (1996) 1.49
Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome. Fertil Steril (1995) 1.47
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer (1995) 1.44
Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report. Gynecol Oncol (2005) 1.43
Generation of multinuclear tartrate-resistant acid phosphatase positive osteoclasts in liquid culture of purified human peripheral blood CD34+ progenitors. Br J Haematol (1997) 1.42
Complete response to pre-operative chemotherapy in stage III B cervical carcinoma. Case report. Br J Obstet Gynaecol (1988) 1.37
Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis. Br J Cancer (1997) 1.33
Spatiotemporal dynamics of the electrical network activity in the root apex. Proc Natl Acad Sci U S A (2009) 1.32
Significance of epidermal growth factor receptor in advanced ovarian cancer. J Clin Oncol (1992) 1.31
GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer (2001) 1.27
A randomized study comparing retroperitoneal drainage with no drainage after lymphadenectomy in gynecologic malignancies. Gynecol Oncol (1997) 1.23
Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression. Int J Cancer (1998) 1.18
Surgery by minilaparotomy in benign gynecologic disease. Obstet Gynecol (1996) 1.15
Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol (1990) 1.12
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol (2002) 1.12
Glutathione S-transferase activity in epithelial ovarian cancer: association with response to chemotherapy and disease outcome. Ann Oncol (1997) 1.12
HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population. J Oral Pathol Med (1999) 1.10
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res (1999) 1.10
Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy. Hum Reprod (2001) 1.10
Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium. Biol Reprod (2001) 1.09
Antenatal phenobarbital in preventing intraventricular hemorrhage in premature newborns. Fetal Ther (1988) 1.07
Interleukin-6 serum levels in patients with gynecological tumors. Int J Cancer (1994) 1.05
Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res (1993) 1.03
bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues. Clin Cancer Res (1998) 1.03
Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol (1993) 1.02
Significance of epidermal growth factor receptor expression in primary human endometrial cancer. Int J Cancer (1994) 1.02
Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer (1991) 1.01
Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. Br J Cancer (1995) 1.01
Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br J Cancer (1999) 0.99
Dilute ornitin vasopressin and a myoma drill for laparoscopic myomectomy. J Am Assoc Gynecol Laparosc (1999) 0.99
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer (1992) 0.99
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother Pharmacol (1991) 0.98
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. Dig Liver Dis (2004) 0.98
Correlation between the American Fertility Society classifications of adnexal adhesions and distal tubal occlusion, salpingoscopy, and reproductive outcome in tubal surgery. Fertil Steril (1995) 0.97
A primary amelanotic melanoma of the vagina diagnosed by immunocytochemistry. Int J Gynaecol Obstet (1989) 0.97
p21WAF1/CIP1 protein expression in primary ovarian cancer. Int J Oncol (2000) 0.96
Randomized clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma. Obstet Gynecol (1989) 0.96
Pelvic lymphocele following radical para-aortic and pelvic lymphadenectomy for cervical carcinoma: incidence rate and percutaneous management. Obstet Gynecol (1990) 0.95
p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis. Clin Cancer Res (2000) 0.95
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients. Breast Cancer Res Treat (1988) 0.95
p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer. Br J Cancer (1999) 0.95
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer (1998) 0.95
No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Transplant Proc (2005) 0.95
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors. Br J Cancer (2000) 0.94
Uterine myomectomy in pregnant women. Fetal Diagn Ther (2001) 0.94
A study of the presence of B. burgdorferi, Anaplasma (previously Ehrlichia) phagocytophilum, Rickettsia, and Babesia in Ixodes ricinus collected within the territory of Belluno, Italy. Vector Borne Zoonotic Dis (2006) 0.94
Short-term effects of maternal oxygen administration on blood flow velocity waveforms in healthy and growth-retarded fetuses. Am J Obstet Gynecol (1988) 0.93
Ovarian fibrothecoma: sonographic and histologic findings. Gynecol Obstet Invest (1991) 0.93
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer. Br J Cancer (2003) 0.93
Classical and nerve-sparing radical hysterectomy: an evaluation of the risk of injury to the autonomous pelvic nerves. Surg Radiol Anat (2003) 0.92
Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas. Int J Cancer (1997) 0.92
Studies on the metabolism of C-19 steroids in the human foeto-placental unit. I. Neutral metabolites formed from dehydroepiandrosterone and dehydroepiandrosterone sulphate by the placenta at midpregnancy. Acta Endocrinol (Copenh) (1967) 0.92
Concurrent HPV infection in oral and genital mucosa. J Oral Pathol Med (1998) 0.92
Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod (1997) 0.91
Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships. Anticancer Drug Des (1995) 0.91
Elevated plasma levels of beta-thromboglobulin in breast cancer. Oncology (1986) 0.91
Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors. Br J Cancer (1994) 0.91
Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies. Obstet Gynecol (1992) 0.90
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma. Gynecol Oncol (1994) 0.90
Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management. Clin Infect Dis (2003) 0.89
Analysis of 138 consecutive ovarian cancer patients: incidence and characteristics of familial cases. Gynecol Oncol (1990) 0.89
Recombinant human leukocyte interferon-alpha 2b stimulates the synthesis and release of a 90K tumor-associated antigen in human breast cancer cells. Int J Cancer (1988) 0.89
Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines. J Cancer Res Clin Oncol (1988) 0.88
Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells. Int J Cancer (1996) 0.88
Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. Br J Cancer (1996) 0.88
Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol (2000) 0.88
Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer. Cancer Lett (1998) 0.88
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines. Int J Cancer (1993) 0.88
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids. Br J Haematol (1990) 0.88
Utero-placental blood flow velocity waveforms as predictors of pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol (1987) 0.88
Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br J Cancer (1990) 0.88
Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin. Eur J Cancer (1996) 0.88
Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study. Obstet Gynecol (1988) 0.88
Epidermal growth factor receptor expression in gynecological malignancies. Gynecol Obstet Invest (1989) 0.88
Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II). Gynecol Oncol (1992) 0.87
A combination of platinum and tamoxifen in advanced ovarian cancer failing platinum-based chemotherapy: results of a Phase II study. Int J Gynecol Cancer (2002) 0.87
Expression of cell-cycle-associated proteins pRB2/p130 and p27kip in vulvar squamous cell carcinomas. Hum Pathol (2001) 0.87
Correlation between endometriosis-associated dysmenorrhea and the presence of typical or atypical lesions. Fertil Steril (1997) 0.87
Studies on the metabolism of C-19 steroids in the human foeto-placental unit. 4. Aromatisation and hydroxylation products formed by previable foetuses perfused withandrostenedione and testosterone. Acta Endocrinol (Copenh) (1968) 0.87
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters. J Clin Oncol (1996) 0.87
Heavy metal distribution between contaminated soil and Paulownia tomentosa, in a pilot-scale assisted phytoremediation study: influence of different complexing agents. Chemosphere (2008) 0.87
The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab (1997) 0.86
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cells. Int J Cancer (1994) 0.86
Operative laparoscopy for ovarian cysts. Excision vs. aspiration. J Reprod Med (1996) 0.85
Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues. Cancer Detect Prev (2000) 0.85
Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol (1999) 0.85
Minilaparotomy for type II and III radical hysterectomy: technique, feasibility, and complications. Int J Gynecol Cancer (2004) 0.85
Osmotic actuation modelling for innovative biorobotic solutions inspired by the plant kingdom. Bioinspir Biomim (2013) 0.85
Presence of human papillomavirus and Epstein-Barr virus in the cervix of women infected with the human immunodeficiency virus. J Med Virol (2000) 0.84
Recombinant alpha-2b-interferon dynamic test as a potential tool in predicting disease status during second look in ovarian cancer. A preliminary report. Cancer (1991) 0.84
CA 15-3 as a tumor marker in gynecological malignancies. Gynecol Oncol (1988) 0.84
Abnormal fetal cerebral blood flow velocity waveforms as a sign of an aneurysm of the vein of Galen. Fetal Ther (1987) 0.84